Skip to content

DEVELOPING PRODUCTS IN PURSUIT OF ENHANCED CLINICAL OUTCOMES WITH NOVEL BIOACTIVE MATERIALS

To stay on the cutting edge of spinal innovation, CES reinvests a substantial percentage of it’s annual revenues back into the research and development of new innovative technologies. It is a long-term commitment; one of our guiding principles.

CES’s objective is to develop every year, in partnership with surgeons and strategic partners, outstanding new spinal technologies that are not only clinically relevant but are also game changers within the spine industry.

Our management team believes that this strategy will keep CES ahead of it’s competition and create extreme value.

We are in the process of establishing Centers of Excellence for our Research and Development projects. In each of these Centers of Excellence, CES researchers work continuously to develop the spinal technologies of tomorrow.

CONTACT US

HAVING A ‘PATIENT FIRST’ MENTALITY AND ABIDING BY EXTREME ETHICS RELATIVE TO SURGEON RELATIONSHIPS IS AT THE CORE OF OUR ORGANIC DEVELOPMENT INITIATIVES.

REQUEST MORE INFORMATION

WHY CUTTING EDGE SPINE

CES provides the spine marketplace with transformational spinal technologies that are ‘passively smart’ in nature in addition to offering extensive experience as a Team relative to organic product development, regulatory affairs, materials science, biomechanical engineering, product commercialization and supply chain management.

OUR 510(k) PORTFOLIO INCLUDES

  • T-FIX™ 3DSI Joint Fusion System
  • EVOL®SI Joint Fusion System
  • EVOSha Lumbar Interbody System
  • EVOL®ha-C Cervical Interbody System
  • EVOL®ha-D Direct Lateral System
  • nuMIS™ semi-rigid lumbar plating system
CONTACT US
The 3D printed T-FIX™ 3DSI Joint Fusion System, intended to reat dysfunction of the sacroiliac joint, is a patented ‘passively smart’ SI Joint Fustion System designed with an emphasis on optimal osseointegration as supported by solid science.
This technology improves osseointegration through the combination of high wettability and optimal surface chemistry (with optimized nano-roughness) that mediates bioactivity and specific protein adsorption to the implant.
Invibio™ Biomaterial Solutions’ PEEK-OPTIMA® HA Enhanced is a material enhancement in spinal device technology. Hydroxyapatite (HA), a well-known osteoconductive material, is fully integrated with PEEK-OPTIMA® Natural, making it available on all surfaces of a device.
EVOSha is the first HA enhanced PEEK Lumbar Interbody system to be FDA cleared (i.e. 510k) in the United States.
This technology improves osseointegration through the combination of high wettability and optimal surface chemistry (with optimized nano-roughness) that mediates bioactivity and specific protein adsorption to the implant.
REQUEST A DEMO